rs761312032

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The ENST00000415950.5(SCN1B):​c.611A>G​(p.Gln204Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000883 in 1,585,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q204Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000084 ( 0 hom. )

Consequence

SCN1B
ENST00000415950.5 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.545

Publications

2 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.117182076).
BP6
Variant 19-35033902-A-G is Benign according to our data. Variant chr19-35033902-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 470181.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.00000837 (12/1433328) while in subpopulation AMR AF = 0.00023 (9/39114). AF 95% confidence interval is 0.00012. There are 0 homozygotes in GnomAdExome4. There are 6 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1BNM_001037.5 linkc.448+163A>G intron_variant Intron 3 of 5 ENST00000262631.11 NP_001028.1 Q07699-1
SCN1BNM_199037.5 linkc.611A>G p.Gln204Arg missense_variant Exon 3 of 3 NP_950238.1 Q07699-2
SCN1BNM_001321605.2 linkc.349+163A>G intron_variant Intron 3 of 5 NP_001308534.1 Q07699A0A1W2PR05

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1BENST00000262631.11 linkc.448+163A>G intron_variant Intron 3 of 5 1 NM_001037.5 ENSP00000262631.3 Q07699-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152118
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000457
AC:
9
AN:
197112
AF XY:
0.0000470
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000251
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000118
Gnomad OTH exome
AF:
0.000194
GnomAD4 exome
AF:
0.00000837
AC:
12
AN:
1433328
Hom.:
0
Cov.:
33
AF XY:
0.00000845
AC XY:
6
AN XY:
710356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32754
American (AMR)
AF:
0.000230
AC:
9
AN:
39114
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25622
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38114
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83612
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5732
European-Non Finnish (NFE)
AF:
0.00000182
AC:
2
AN:
1097420
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152118
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
74310
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
41416
American (AMR)
AF:
0.000131
AC:
2
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000169
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
May 10, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported using an alternate transcript of the gene; Reported previously in an asymptomatic patient with an idiopathic type 1 Brugada ECG pattern and no family history (PMID: 22840528); In silico analysis indicates that this variant does not alter splicing; This variant is associated with the following publications: (PMID: 23874304, 22840528) -

Brugada syndrome 5 Benign:1
Dec 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
4.5
DANN
Benign
0.92
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.26
T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.76
T
PhyloP100
-0.55
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.2
N;.
REVEL
Uncertain
0.54
Sift
Benign
0.20
T;.
Sift4G
Uncertain
0.024
D;.
Polyphen
0.0020
B;.
Vest4
0.65
MutPred
0.14
Gain of sheet (P = 0.0221);.;
MVP
0.69
MPC
0.78
ClinPred
0.017
T
GERP RS
-2.2
gMVP
0.16
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761312032; hg19: chr19-35524806; API